docosapentaenoic-acid and Death--Sudden--Cardiac

docosapentaenoic-acid has been researched along with Death--Sudden--Cardiac* in 2 studies

Other Studies

2 other study(ies) available for docosapentaenoic-acid and Death--Sudden--Cardiac

ArticleYear
Why docosapentaenoic acid is not included in the Omega-3 Index.
    Prostaglandins, leukotrienes, and essential fatty acids, 2018, Volume: 135

    As currently defined, the Omega-3 Index comprises eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), but not docosapentaenoic acid (DPA) in erythrocytes. In fish and many fish oils DPA is detectable (along with EPA and DHA), but sources rich in DPA are scarce. Purified DPA is available, and DPA is a precursor of biologically active molecules, but much remains to be learned about the effects of DPA in humans. In epidemiologic studies, erythrocyte DPA did not predict risk for total mortality, sudden cardiac death, or other relevant cardiovascular events, and, more importantly, did not improve prediction of these events when included along with EPA and DHA, the original Omega-3 Index. We conclude that current scientific evidence does not support including DPA into the Omega-3 Index.

    Topics: Death, Sudden, Cardiac; Erythrocytes; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Fish Oils; Humans; Mortality; Risk Factors

2018
Fatty acids and other risk factors for sudden cardiac death in patients starting hemodialysis.
    American journal of nephrology, 2013, Volume: 38, Issue:1

    Little is known about risk factors for sudden cardiac death in hemodialysis patients during the high-risk first year of dialysis. We therefore undertook to identify such risk factors in a nationally representative cohort and were able to include baseline levels of blood fatty acids, some of which influence arrhythmogenicity and sudden cardiac death risk.. The study cohort included 100 patients who died of sudden cardiac death during the first year of hemodialysis and 300 frequency-matched controls. Using the elastic net statistical method, numerous demographic and clinical characteristics were included with baseline total serum levels for 11 major fatty acids (model 1) and with serum phospholipid fractions of these same fatty acids (model 2). Final models included only covariates that had a non-zero coefficient.. In model 1, serum albumin [odds ratio (95% CI): 0.55 (0.33-0.93); p = 0.03] and total serum long-chain n-3 docosapentaenoic acid [0.70 (0.51-0.97); p = 0.03] were inversely associated with the odds of sudden cardiac death, while the total serum saturated fatty acid level had a direct association [1.01 (1.00-1.02); p = 0.03]. In model 2, serum albumin and docosapentaenoic acid remained inversely associated with sudden cardiac death in a similar manner as in model 1. Pulse pressure also had an inverse association [0.96 (0.93-1.00); p < 0.05].. Several factors, including blood content of docosapentaenoic acid and saturated fatty acids, were associated with the odds of sudden cardiac death during year one of hemodialysis. These results raise the possibility that dietary modification may reduce sudden death risk.

    Topics: Aged; Aged, 80 and over; Arachidonic Acid; Arrhythmias, Cardiac; Case-Control Studies; Cohort Studies; Death, Sudden, Cardiac; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids; Fatty Acids, Unsaturated; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Odds Ratio; Prospective Studies; Renal Dialysis; Risk Factors; Serum Albumin

2013